SC5DL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.507200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.922600E-01
Normal-vs-Stage2
6.675800E-01
Normal-vs-Stage3
7.482000E-01
Normal-vs-Stage4
2.482200E-01
Stage1-vs-Stage2
6.829000E-01
Stage1-vs-Stage3
2.712800E-01
Stage1-vs-Stage4
4.371200E-01
Stage2-vs-Stage3
3.811200E-01
Stage2-vs-Stage4
2.074800E-01
Stage3-vs-Stage4
1.252800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.732200E-01
Normal-vs-AfricanAmerican
1.455170E-01
Normal-vs-Asian
8.248800E-01
Caucasian-vs-AfricanAmerican
2.604200E-01
Caucasian-vs-Asian
8.602000E-01
AfricanAmerican-vs-Asian
3.903400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.369600E-01
Normal-vs-Female
6.696200E-01
Male-vs-Female
8.179600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.487000E-01
Normal-vs-Age(41-60Yrs)
4.809800E-01
Normal-vs-Age(61-80Yrs)
6.987400E-01
Normal-vs-Age(81-100Yrs)
9.330000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.700620E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.139200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.860600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.284400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.320000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.358400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.374600E-01
Normal-vs-Daily Drinker
9.102200E-01
Normal-vs-Weekly Drinker
9.180800E-01
Normal-vs-Occasional Drinker
5.340400E-01
Normal-vs-Social Drinker
8.016600E-01
Non Drinker-vs-Daily Drinker
1.974620E-01
Non Drinker-vs-Weekly Drinker
2.742600E-01
Non Drinker-vs-Occasional Drinker
5.297800E-01
Non Drinker-vs-Social Drinker
5.357200E-01
Daily Drinker-vs-Weekly Drinker
9.778800E-01
Daily Drinker-vs-Occasional Drinker
1.281000E-01
Daily Drinker-vs-Social Drinker
5.198600E-01
Weekly Drinker-vs-Occasional Drinker
1.457790E-01
Weekly Drinker-vs-Social Drinker
5.497600E-01
Occasional Drinker-vs-Social Drinker
2.739800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.806200E-02
Normal-vs-Grade 2
1.550240E-02
Normal-vs-Grade 3
1.448190E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.762400E-01
Grade 1-vs-Grade 3
8.981200E-01
Grade 1-vs-Grade 4
7.806200E-02
Grade 2-vs-Grade 3
2.237200E-01
Grade 2-vs-Grade 4
1.550240E-02
Grade 3-vs-Grade 4
1.448190E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.540400E-01
Normal-vs-NonDiabetic
6.357200E-01
Diabetic-vs-NonDiabetic
1.891200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.550400E-01
Normal-vs-NoPancreatitis
7.014400E-01
Pancreatitis-vs-NoPancreatitis
8.194400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.854400E-01
Normal-vs-N1
6.929000E-01
N0-vs-N1
2.896600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.081400E-01
Normal-vs-TP53-NonMutant
6.678000E-01
TP53-Mutant-vs-TP53-NonMutant
1.434830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
